Skip to content

Microdosing: all studies

Page 20 of 56: studies 191 to 200 of 555, newest first. Back to the microdosing overview

Research

Microdosing for drug delivery application—A review

Sensors and Actuators A Physical May 11, 2021 Agnes Beate Bußmann, Lorenz Maximilian Grünerbel, Claudia Patricia Durasiewicz et al. 53 citations

There is an increasing amount of research on microfluidic actuators with the aim to improve drug dosing applications. Micropumps are promising as they reduce the size and energy consumption of dosing concepts and enable new therapies. Even though there are evident advantages, there are only few examples of industrial microdosing units and micropump technology has not yet found widespread...

Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study

Psychopharmacology April 30, 2021 Michiel van Elk, George Fejer, Pascal Lempe et al. 53 citations

Abstract There is an increased societal trend to engage in microdosing, in which small sub-hallucinogenic amounts of psychedelics are consumed on a regular basis. Following subjective reports that microdosing enhances the experience of nature and art, in the present study we set out to study the effects of psilocybin microdosing on feelings of awe and art perception. In this preregistered...

Microdosing flexibility in an efficient supply chain

Journal of Operations Management April 1, 2021 Lance W. Saunders, Jason R.W. Merrick, Mary C. Holcomb

Abstract: The designation of a supply chain as efficient or responsive has often been considered to be a dichotomy in theory and practice. This technical note explores this issue by describing an engagement by the research team with a large consumer packaged‐goods company within their cosmetics supply chain during the launch of a new product family. The company was experiencing high...

Exploring the relationship between microdosing, personality and emotional insight: A prospective study

Journal of Psychedelic Studies March 26, 2021 Hannah Marie Dressler, Stephen Bright, Vince Polito 12 citations

Abstract Backround and aims Having entered the recent public and research zeitgeist, microdosing involves consuming sub-perceptual doses of psychedelic drugs, allegedly to enhance performance, creativity, and wellbeing. The results of research to date have been mixed. Whereas most studies have reported positive impacts of microdosing, some microdosers have also reported adverse effects. In...

DOI: 10.1556/2054.2021.00157 (opens in new tab) Full text (opens in new tab) Conscientiousness Neuroticism Personality Extraversion and introversion +2

Using Microdosing to Induct Patients Into a Long-Acting Injectable Buprenorphine Depot Medication in Low Threshold Community Settings: A Case Study

Frontiers in Pharmacology March 23, 2021 Joseph Tay Wee Teck, Alexander Baldacchino, Lauren Gibson et al.

Healthcare innovation has never been more important as it is now when the world is facing up to the unprecedented challenges brought by the COVID-19 pandemic. Within addictions services in Scotland, the priority has been to tackle our rising drug related death rate by maintaining and improving access to treatment while protecting frontline workers and managing operational challenges as a result...

Self-blinding citizen science to explore psychedelic microdosing.

Elife March 2, 2021 Balázs Szigeti, Laura Kärtner, Allan Blemings et al. 192 citations

Microdosing is the practice of regularly using low doses of psychedelic drugs. Anecdotal reports suggest that microdosing enhances well-being and cognition; however, such accounts are potentially biased by the placebo effect. This study used a 'self-blinding' citizen science initiative, where participants were given online instructions on how to incorporate placebo control into their...

Sociological investigations of human enhancement drugs: The case of microdosing psychedelics

International Journal of Drug Policy January 28, 2021 Dimitrios Liokaftos 17 citations

Microdosing psychedelics is the regular use of sub-perceptive threshold doses of substances such as lysergic acid diethylamide (LSD) and psilocybin ('magic') mushrooms. The phenomenon has attracted increasing public and scientific attention in numerous countries in recent years. This commentary looks at microdosing psychedelics as an emerging facet of human enhancement through drugs. After...

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing

Scientific Reports January 21, 2021 Laura Kaertner, Michael B. Steinborn, Hannes Kettner et al. 152 citations

Abstract Psychedelic microdosing describes the ingestion of near-threshold perceptible doses of classic psychedelic substances. Anecdotal reports and observational studies suggest that microdosing may promote positive mood and well-being, but recent placebo-controlled studies failed to find compelling evidence for this. The present study collected web-based mental health and related data using...

Midazolam microdosing applied in early clinical development for drug–drug interaction assessment

British Journal of Clinical Pharmacology 2021 Sabrina T. Wiebe, Andreas Huennemeyer, Werner Kadus et al.

Aims: We aimed to incorporate a pharmacologically inactive midazolam microdose into early clinical studies for the assessment of CYP3A drug–drug interaction liability. Methods: Three early clinical studies were conducted with substances (Compounds A, B and C) which gave positive CYP3A perpetrator signals in vitro. A 75 μg dose of midazolam was administered alone (baseline CYP3A activity)...